Gpax Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 25-12-2024
- Paid Up Capital ₹ 8.80 Cr
as on 25-12-2024
- Company Age 10 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 17.38 Cr
as on 25-12-2024
- Revenue -43.02%
(FY 2022)
- Profit -17723.73%
(FY 2022)
- Ebitda -139.00%
(FY 2022)
- Net Worth -50.78%
(FY 2022)
- Total Assets -23.33%
(FY 2022)
About Gpax Pharmaceuticals
The Corporate was formerly known as Celogen Generics Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 8.80 Cr.
The company currently has active open charges totaling ₹17.38 Cr.
Vijaykumar Nair, Rabi Nayak, Thykoottathil Matthews, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24233MH2014PTC258452
- Company No.
258452
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Sep 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Gpax Pharmaceuticals?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikash Shah  | Director | 19-Jan-2024 | Current |
Rabi Nayak  | Director | 30-Sep-2014 | Current |
| Amit Rajan | Director | 02-Jan-2015 | Current |
| Vijaykumar Nair | Director | 30-Sep-2014 | Current |
| Thykoottathil Matthews | Director | 30-Sep-2014 | Current |
| Anuj Shah | Director | 19-Jan-2024 | Current |
Financial Performance of Gpax Pharmaceuticals.
Gpax Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 43.02% decrease. The company also saw a substantial fall in profitability, with a 17723.73% decrease in profit. The company's net worth observed a substantial decline by a decrease of 50.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gpax Pharmaceuticals?
In 2022, Gpax Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Celogen Pharma Private LimitedActive 19 years 9 monthsVijaykumar Nair and Thykoottathil Matthews are mutual person
Celogen Laboratories Private LimitedActive 12 years 11 monthsVijaykumar Nair, Rabi Nayak and 1 more are mutual person
Agam And Gem Laboratories Private LimitedActive 29 years 23 daysVijaykumar Nair, Rabi Nayak and 1 more are mutual person
- Celogen Lifescience & Technologies Private LimitedActive 14 years 2 months
Vijaykumar Nair, Rabi Nayak and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Mar 2023 | ₹2.55 Cr | Open |
Others Creation Date: 27 Jul 2018 | ₹9.75 M | Open |
Others Creation Date: 18 Jul 2018 | ₹2.50 Cr | Open |
How Many Employees Work at Gpax Pharmaceuticals?
Gpax Pharmaceuticals has a workforce of 184 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gpax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gpax Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
